Predictive and prognostic value of B-cell gene-expression signatures and B-cell receptor (BCR) repertoires in HER2-positive breast cancer: a correlative analysis of the CALGB 40601 (Alliance) clinical trial.
- Citation:
- Ann Oncol vol 30 (5) v55 abst 174O
- Meeting Instance:
- ESMO 2019
- Year:
- 2019
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3314
- Pharmas:
- GSK
- Grants:
- U10CA180821, U10CA180882, U24CA196171, P50-CA58223
- Corr. Author:
- Authors:
- Aranzazu Fernandez-Martinez Maki Tanioka Cheng Fan Joel S. Parker Katherine A. Hoadley Ian Krop Ann Partridge Lisa Carey Charles Perou
- Networks:
- LAPS-CT018, LAPS-MA036, LAPS-NC007
- Study
- CALGB-40601
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: